Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2019

Open Access 01-12-2019 | Research

“Be an ambassador for change that you would like to see”: a call to action to all stakeholders for co-creation in healthcare and medical research to improve quality of life of people with a neuromuscular disease

Authors: Anna Ambrosini, Ros Quinlivan, Valeria A. Sansone, Ingeborg Meijer, Guus Schrijvers, Aad Tibben, George Padberg, Maarten de Wit, Ellen Sterrenburg, Alexandre Mejat, Alexandra Breukel, Michal Rataj, Hanns Lochmüller, Raffaella Willmann, on behalf of the 235th ENMC workshop study group

Published in: Orphanet Journal of Rare Diseases | Issue 1/2019

Login to get access

Abstract

Background

Patient and public involvement for co-creation is increasingly recognized as a valuable strategy to develop healthcare research targeting patients’ real needs. However, its practical implementation is not as advanced and unanimously accepted as it could be, due to cultural differences and complexities of managing healthcare programs and clinical studies, especially in the rare disease field.

Main body

The European Neuromuscular Centre, a European foundation of patient organizations, involved its key stakeholders in a special workshop to investigate the position of the neuromuscular patient community with respect to healthcare and medical research to identify and address gaps and bottlenecks. The workshop took place in Milan (Italy) on January 19–20, 2018, involving 45 participants who were mainly representatives of the patient community, but also included experts from clinical centers, industry and regulatory bodies. In order to provide practical examples and constructive suggestions, specific topics were identified upfront. The first set of issues concerned the quality of life at specific phases of a patient’s life, such as at the time of diagnosis or during pediatric to adult transition, and patient involvement in medical research on activities in daily living including patient reported outcome measures. The second set of issues concerned the involvement of patients in the management of clinical research tools, such as registries and biobanks, and their participation in study design or marketing authorization processes. Introductory presentations were followed by parallel working group sessions, to gain constructive contributions from all participants. The concept of shared decision making was used to ensure, in discussions, a partnership-based identification of the wishes and needs of all stakeholders involved, and the “ladder of participation” tool served as a model to evaluate the actual and the desired level of patients’ involvement in all topics addressed. A general consensus on the outcome of the meeting was collected during the final plenary session.
This paper reports the outcome of the workshop and the specific suggestions derived from the analysis of the first set of topics, related to quality of life. The outcomes of the second set of topics are reported elsewhere and are only briefly summarized herein for the sake of completeness.

Conclusions

The neuromuscular community proved to be very active and engaged at different levels in the healthcare initiatives of interest. The workshop participants critically discussed several topics, providing practical examples where different stakeholders could play a role in making a change and bridging gaps. Overall, they indicated the need for education of all stakeholders for better communication, where everyone should become an ambassador to promote real change. Support should also come from institutions and healthcare bodies both at structural and economic level.
Literature
2.
go back to reference Elberse JE, Caron-Flinterman JF, Broerse JE. Patient-expert partnerships in research: how to stimulate inclusion of patient perspectives. Health Expect. 2011;14:225–39.CrossRefPubMed Elberse JE, Caron-Flinterman JF, Broerse JE. Patient-expert partnerships in research: how to stimulate inclusion of patient perspectives. Health Expect. 2011;14:225–39.CrossRefPubMed
3.
go back to reference Greenhalgh T, Jackson C, Shaw S, Janamian T. Achieving research impact through co-creation in community-based health services. Literature review and Case study. Milbank Q. 2016;94:392–429.CrossRefPubMedCentralPubMed Greenhalgh T, Jackson C, Shaw S, Janamian T. Achieving research impact through co-creation in community-based health services. Literature review and Case study. Milbank Q. 2016;94:392–429.CrossRefPubMedCentralPubMed
4.
go back to reference Carman KL, Workman TA. Engaging patients and consumers in research evidence: applying the conceptual model of patient and family engagement. Patient Educ Couns. 2017;100:25–9.CrossRefPubMed Carman KL, Workman TA. Engaging patients and consumers in research evidence: applying the conceptual model of patient and family engagement. Patient Educ Couns. 2017;100:25–9.CrossRefPubMed
5.
go back to reference Mavris M, Le Cam Y. Involvement of patient organisations in research and development of orphan drugs for rare diseases in europe. Mol Syndromol. 2012;3:237–43.PubMedPubMedCentral Mavris M, Le Cam Y. Involvement of patient organisations in research and development of orphan drugs for rare diseases in europe. Mol Syndromol. 2012;3:237–43.PubMedPubMedCentral
7.
go back to reference Geissler J, Ryll B, di Priolo SL, Uhlenhopp M. Improving patient involvement in medicines Research and Development:: a practical roadmap. Ther Innov Regul Sci. 2017;51:612–9.PubMed Geissler J, Ryll B, di Priolo SL, Uhlenhopp M. Improving patient involvement in medicines Research and Development:: a practical roadmap. Ther Innov Regul Sci. 2017;51:612–9.PubMed
8.
go back to reference Clayman ML, Bylund CL, Chewning B, Makoul G. The impact of patient participation in health decisions within medical encounters. A systematic review. Med Decis Mak. 2016;36:427–52.CrossRef Clayman ML, Bylund CL, Chewning B, Makoul G. The impact of patient participation in health decisions within medical encounters. A systematic review. Med Decis Mak. 2016;36:427–52.CrossRef
10.
go back to reference Rudel R, Nigro G, Poortman Y. Ten years of ENMC--from a patients’ initiative to a successful European research institution: the story of the European neuromuscular Centre. Neuromuscul Disord. 2000;10:75–82.CrossRefPubMed Rudel R, Nigro G, Poortman Y. Ten years of ENMC--from a patients’ initiative to a successful European research institution: the story of the European neuromuscular Centre. Neuromuscul Disord. 2000;10:75–82.CrossRefPubMed
11.
go back to reference van Engelen B, Zollinger D, Pohlschmidt M, Ambrosini A, Rahbek J. The European NeuroMuscular Centre (ENMC): 20 years on. Neuromuscul Disord. 2013;23:375–6.CrossRefPubMed van Engelen B, Zollinger D, Pohlschmidt M, Ambrosini A, Rahbek J. The European NeuroMuscular Centre (ENMC): 20 years on. Neuromuscul Disord. 2013;23:375–6.CrossRefPubMed
12.
go back to reference Makoul G, Clayman ML. An integrative model of shared decision making in medical encounters. Patient Educ Couns. 2006;60:301–12.CrossRefPubMed Makoul G, Clayman ML. An integrative model of shared decision making in medical encounters. Patient Educ Couns. 2006;60:301–12.CrossRefPubMed
13.
go back to reference Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27:1361–7.CrossRefPubMedCentralPubMed Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27:1361–7.CrossRefPubMedCentralPubMed
14.
go back to reference Elwyn G, Durand MA, Song J, Aarts J, Barr PJ, Berger Z, Cochran N, Frosch D, Galasinski D, Gulbrandsen P, et al. A three-talk model for shared decision making: multistage consultation process. BMJ. 2017;359:j4891.CrossRefPubMedCentralPubMed Elwyn G, Durand MA, Song J, Aarts J, Barr PJ, Berger Z, Cochran N, Frosch D, Galasinski D, Gulbrandsen P, et al. A three-talk model for shared decision making: multistage consultation process. BMJ. 2017;359:j4891.CrossRefPubMedCentralPubMed
15.
go back to reference Arnstein SR. Ladder of citizen participation. J Am Inst Plann. 1969;35:216–24.CrossRef Arnstein SR. Ladder of citizen participation. J Am Inst Plann. 1969;35:216–24.CrossRef
16.
go back to reference Tritter JQ, McCallum A. The snakes and ladders of user involvement: moving beyond Arnstein. Health Policy. 2006;76:156–68.CrossRefPubMed Tritter JQ, McCallum A. The snakes and ladders of user involvement: moving beyond Arnstein. Health Policy. 2006;76:156–68.CrossRefPubMed
17.
go back to reference Legare F, Adekpedjou R, Stacey D, Turcotte S, Kryworuchko J, Graham ID, et al. Interventions for increasing the use of shared decision making by healthcare professionals. Cochrane Database Syst Rev. 2018;7:CD006732.PubMed Legare F, Adekpedjou R, Stacey D, Turcotte S, Kryworuchko J, Graham ID, et al. Interventions for increasing the use of shared decision making by healthcare professionals. Cochrane Database Syst Rev. 2018;7:CD006732.PubMed
18.
go back to reference Abelson J, Warren ME, Forest PG. The future of public deliberation on health issues. Hast Cent Rep. 2012;42:27–9.CrossRef Abelson J, Warren ME, Forest PG. The future of public deliberation on health issues. Hast Cent Rep. 2012;42:27–9.CrossRef
19.
go back to reference de Wit MP, Kvien TK, Gossec L. Patient participation as an integral part of patient-reported outcomes development ensures the representation of the patient voice: a case study from the field of rheumatology. RMD Open. 2015;1:e000129.CrossRefPubMedCentralPubMed de Wit MP, Kvien TK, Gossec L. Patient participation as an integral part of patient-reported outcomes development ensures the representation of the patient voice: a case study from the field of rheumatology. RMD Open. 2015;1:e000129.CrossRefPubMedCentralPubMed
20.
go back to reference Abma TA, Nierse CJ, Widdershoven GA. Patients as partners in responsive research: methodological notions for collaborations in mixed research teams. Qual Health Res. 2009;19:401–15.CrossRefPubMed Abma TA, Nierse CJ, Widdershoven GA. Patients as partners in responsive research: methodological notions for collaborations in mixed research teams. Qual Health Res. 2009;19:401–15.CrossRefPubMed
21.
go back to reference Lochmüller H, Ambrosini A, van Engelen B, Hansson M, Tibben A, Breukel A, et al. The position of neuromuscular patients in shared decision making. Report from the 235th ENMC workshop: Milan, Italy, January 19-20, 2018. J Neuromuscul Dis. 2019;6(1):161–72.CrossRefPubMed Lochmüller H, Ambrosini A, van Engelen B, Hansson M, Tibben A, Breukel A, et al. The position of neuromuscular patients in shared decision making. Report from the 235th ENMC workshop: Milan, Italy, January 19-20, 2018. J Neuromuscul Dis. 2019;6(1):161–72.CrossRefPubMed
23.
go back to reference Md W, Hajos T. Health-related quality of life. In: Springer, editor. Encyclopedia of behavioral medicine. New York: Gellman M.D. Turner J.R; 2013. Md W, Hajos T. Health-related quality of life. In: Springer, editor. Encyclopedia of behavioral medicine. New York: Gellman M.D. Turner J.R; 2013.
25.
go back to reference MacLeod R, Tibben A, Frontali M, Evers-Kiebooms G, Jones A, Martinez-Descales A, Roos RA, Editorial C. Working group ‘Genetic testing Counselling’ of the European Huntington disease N. recommendations for the predictive genetic test in Huntington's disease. Clin Genet. 2013;83:221–31.CrossRefPubMed MacLeod R, Tibben A, Frontali M, Evers-Kiebooms G, Jones A, Martinez-Descales A, Roos RA, Editorial C. Working group ‘Genetic testing Counselling’ of the European Huntington disease N. recommendations for the predictive genetic test in Huntington's disease. Clin Genet. 2013;83:221–31.CrossRefPubMed
26.
go back to reference Craufurd D, MacLeod R, Frontali M, Quarrell O, Bijlsma EK, Davis M, et al. Diagnostic genetic testing for Huntington's disease. Pract Neurol. 2015;15:80–4.CrossRefPubMed Craufurd D, MacLeod R, Frontali M, Quarrell O, Bijlsma EK, Davis M, et al. Diagnostic genetic testing for Huntington's disease. Pract Neurol. 2015;15:80–4.CrossRefPubMed
27.
go back to reference Kwon JM, Abdel-Hamid HZ, Al-Zaidy SA, Mendell JR, Kennedy A, Kinnett K, et al. Clinical follow-up for Duchenne Muscular Dystrophy newborn screening: a proposal. Muscle Nerve. 2016;54:186–91.CrossRefPubMedCentralPubMed Kwon JM, Abdel-Hamid HZ, Al-Zaidy SA, Mendell JR, Kennedy A, Kinnett K, et al. Clinical follow-up for Duchenne Muscular Dystrophy newborn screening: a proposal. Muscle Nerve. 2016;54:186–91.CrossRefPubMedCentralPubMed
28.
go back to reference Ross LF, Clarke AJ. A historical and current review of newborn screening for neuromuscular disorders from around the world: lessons for the United States. Pediatr Neurol. 2017;77:12–22.CrossRefPubMed Ross LF, Clarke AJ. A historical and current review of newborn screening for neuromuscular disorders from around the world: lessons for the United States. Pediatr Neurol. 2017;77:12–22.CrossRefPubMed
29.
go back to reference Scoto M, Finkel R, Mercuri E, Muntoni F. Genetic therapies for inherited neuromuscular disorders. Lancet Child Adolesc Health. 2018;2:600–9.CrossRefPubMed Scoto M, Finkel R, Mercuri E, Muntoni F. Genetic therapies for inherited neuromuscular disorders. Lancet Child Adolesc Health. 2018;2:600–9.CrossRefPubMed
30.
go back to reference Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17:251–67.CrossRefPubMedCentralPubMed Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17:251–67.CrossRefPubMedCentralPubMed
31.
go back to reference Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, et al. Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan. Lancet Neurol. 2018;17:445–55.CrossRefPubMedCentralPubMed Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, et al. Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan. Lancet Neurol. 2018;17:445–55.CrossRefPubMedCentralPubMed
32.
go back to reference Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al. Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018;28:103–15.CrossRefPubMed Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al. Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018;28:103–15.CrossRefPubMed
33.
go back to reference Glascock J, Sampson J, Haidet-Phillips A, Connolly A, Darras B, Day J, et al. Treatment algorithm for infants diagnosed with spinal Muscular atrophy through newborn screening. J Neuromuscul Dis. 2018;5:145–58.CrossRefPubMedCentralPubMed Glascock J, Sampson J, Haidet-Phillips A, Connolly A, Darras B, Day J, et al. Treatment algorithm for infants diagnosed with spinal Muscular atrophy through newborn screening. J Neuromuscul Dis. 2018;5:145–58.CrossRefPubMedCentralPubMed
34.
go back to reference Rahbek J, Steffensen BF, Bushby K, de Groot IJ. 206th ENMC international workshop: care for a novel group of patients - adults with Duchenne muscular dystrophy Naarden, the Netherlands, 23-25 may 2014. Neuromuscul Disord. 2015;25:727–38.CrossRefPubMed Rahbek J, Steffensen BF, Bushby K, de Groot IJ. 206th ENMC international workshop: care for a novel group of patients - adults with Duchenne muscular dystrophy Naarden, the Netherlands, 23-25 may 2014. Neuromuscul Disord. 2015;25:727–38.CrossRefPubMed
35.
go back to reference Van Ruiten HJ, Marini Bettolo C, Cheetham T, Eagle M, Lochmuller H, Straub V, et al. Why are some patients with Duchenne muscular dystrophy dying young: an analysis of causes of death in north East England. Eur J Paediatr Neurol. 2016;20:904–9.CrossRefPubMed Van Ruiten HJ, Marini Bettolo C, Cheetham T, Eagle M, Lochmuller H, Straub V, et al. Why are some patients with Duchenne muscular dystrophy dying young: an analysis of causes of death in north East England. Eur J Paediatr Neurol. 2016;20:904–9.CrossRefPubMed
37.
go back to reference Lotstein DS, Seid M, Klingensmith G, Case D, Lawrence JM, Pihoker C, et al. Transition from pediatric to adult care for youth diagnosed with type 1 diabetes in adolescence. Pediatrics. 2013;131:e1062–70.CrossRefPubMedCentralPubMed Lotstein DS, Seid M, Klingensmith G, Case D, Lawrence JM, Pihoker C, et al. Transition from pediatric to adult care for youth diagnosed with type 1 diabetes in adolescence. Pediatrics. 2013;131:e1062–70.CrossRefPubMedCentralPubMed
39.
go back to reference Szalda D, Pierce L, Hobbie W, Ginsberg JP, Brumley L, Wasik M, Li Y, Schwartz LA. Engagement and experience with cancer-related follow-up care among young adult survivors of childhood cancer after transfer to adult care. J Cancer Surviv. 2016;10:342–50.CrossRefPubMed Szalda D, Pierce L, Hobbie W, Ginsberg JP, Brumley L, Wasik M, Li Y, Schwartz LA. Engagement and experience with cancer-related follow-up care among young adult survivors of childhood cancer after transfer to adult care. J Cancer Surviv. 2016;10:342–50.CrossRefPubMed
43.
go back to reference de Wit M, Beurskens A, Piskur B, Stoffers E, Moser A. Preparing researchers for patient and public involvement in scientific research: development of a hands-on learning approach through action research. Health Expect. 2018;21:752–63.CrossRefPubMedCentralPubMed de Wit M, Beurskens A, Piskur B, Stoffers E, Moser A. Preparing researchers for patient and public involvement in scientific research: development of a hands-on learning approach through action research. Health Expect. 2018;21:752–63.CrossRefPubMedCentralPubMed
44.
go back to reference Moultrie RR, Lewis MA, Paquin RS, Lucas A, Jarecki J, Peay HL. An evidence-based, community-engaged approach to develop an interactive deliberation tool for pediatric neuromuscular trials. J Genet Couns. 2018;27:416–25.CrossRefPubMed Moultrie RR, Lewis MA, Paquin RS, Lucas A, Jarecki J, Peay HL. An evidence-based, community-engaged approach to develop an interactive deliberation tool for pediatric neuromuscular trials. J Genet Couns. 2018;27:416–25.CrossRefPubMed
45.
go back to reference Messina S, Vita GL, Sframeli M, Mondello S, Mazzone E, D'Amico A, et al. Health-related quality of life and functional changes in DMD: a 12-month longitudinal cohort study. Neuromuscul Disord. 2016;26:189–96.CrossRefPubMedCentralPubMed Messina S, Vita GL, Sframeli M, Mondello S, Mazzone E, D'Amico A, et al. Health-related quality of life and functional changes in DMD: a 12-month longitudinal cohort study. Neuromuscul Disord. 2016;26:189–96.CrossRefPubMedCentralPubMed
46.
go back to reference Klingels K, Mayhew AG, Mazzone ES, Duong T, Decostre V, Werlauff U, et al. Development of a patient-reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD upper limb PROM. Dev Med Child Neurol. 2017;59:224–31.CrossRefPubMed Klingels K, Mayhew AG, Mazzone ES, Duong T, Decostre V, Werlauff U, et al. Development of a patient-reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD upper limb PROM. Dev Med Child Neurol. 2017;59:224–31.CrossRefPubMed
47.
go back to reference Gagnon C, Heatwole C, Hebert LJ, Hogrel JY, Laberge L, Leone M, et al. Report of the third outcome measures in myotonic dystrophy type 1 (OMMYD-3) international workshop Paris, France, June 8, 2015. J Neuromuscul Dis. 2018;5:523–37.CrossRefPubMed Gagnon C, Heatwole C, Hebert LJ, Hogrel JY, Laberge L, Leone M, et al. Report of the third outcome measures in myotonic dystrophy type 1 (OMMYD-3) international workshop Paris, France, June 8, 2015. J Neuromuscul Dis. 2018;5:523–37.CrossRefPubMed
52.
go back to reference Sacristan JA, Aguaron A, Avendano-Sola C, Garrido P, Carrion J, Gutierrez A, Kroes R, Flores A. Patient involvement in clinical research: why, when, and how. Patient Prefer Adherence. 2016;10:631–40.CrossRefPubMedCentralPubMed Sacristan JA, Aguaron A, Avendano-Sola C, Garrido P, Carrion J, Gutierrez A, Kroes R, Flores A. Patient involvement in clinical research: why, when, and how. Patient Prefer Adherence. 2016;10:631–40.CrossRefPubMedCentralPubMed
55.
go back to reference Austin CP, Cutillo CM, Lau LPL, Jonker AH, Rath A, Julkowska D, et al. Future of rare diseases research 2017-2027: an IRDiRC perspective. Clin Transl Sci. 2018;11:21–7.CrossRefPubMed Austin CP, Cutillo CM, Lau LPL, Jonker AH, Rath A, Julkowska D, et al. Future of rare diseases research 2017-2027: an IRDiRC perspective. Clin Transl Sci. 2018;11:21–7.CrossRefPubMed
56.
go back to reference Stein S, Bogard E, Boice N, Fernandez V, Field T, Gilstrap A, et al. Principles for interactions with biopharmaceutical companies: the development of guidelines for patient advocacy organizations in the field of rare diseases. Orphanet J Rare Dis. 2018;13:18.CrossRefPubMedCentralPubMed Stein S, Bogard E, Boice N, Fernandez V, Field T, Gilstrap A, et al. Principles for interactions with biopharmaceutical companies: the development of guidelines for patient advocacy organizations in the field of rare diseases. Orphanet J Rare Dis. 2018;13:18.CrossRefPubMedCentralPubMed
57.
go back to reference Buck D, Gamble C, Dudley L, Preston J, Hanley B, Williamson PR, Young B, Group EPA, Group EPA. From plans to actions in patient and public involvement: qualitative study of documented plans and the accounts of researchers and patients sampled from a cohort of clinical trials. BMJ Open. 2014;4:e006400.CrossRefPubMedCentralPubMed Buck D, Gamble C, Dudley L, Preston J, Hanley B, Williamson PR, Young B, Group EPA, Group EPA. From plans to actions in patient and public involvement: qualitative study of documented plans and the accounts of researchers and patients sampled from a cohort of clinical trials. BMJ Open. 2014;4:e006400.CrossRefPubMedCentralPubMed
58.
go back to reference Boaz A, Hanney S, Borst R, O'Shea A, Kok M. How to engage stakeholders in research: design principles to support improvement. Health Res Policy Syst. 2018;16:60.CrossRefPubMedCentralPubMed Boaz A, Hanney S, Borst R, O'Shea A, Kok M. How to engage stakeholders in research: design principles to support improvement. Health Res Policy Syst. 2018;16:60.CrossRefPubMedCentralPubMed
Metadata
Title
“Be an ambassador for change that you would like to see”: a call to action to all stakeholders for co-creation in healthcare and medical research to improve quality of life of people with a neuromuscular disease
Authors
Anna Ambrosini
Ros Quinlivan
Valeria A. Sansone
Ingeborg Meijer
Guus Schrijvers
Aad Tibben
George Padberg
Maarten de Wit
Ellen Sterrenburg
Alexandre Mejat
Alexandra Breukel
Michal Rataj
Hanns Lochmüller
Raffaella Willmann
on behalf of the 235th ENMC workshop study group
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2019
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-019-1103-8

Other articles of this Issue 1/2019

Orphanet Journal of Rare Diseases 1/2019 Go to the issue